Registration Frequencies

Fig 1) Patient numbers by biologic treatment at inclusion
Last update: | n= | updated weekly
Fig 1) Patient numbers by biologic treatment at inclusion

 

Fig 2) PsoBest registry: patient numbers by non-biologic treatment at inclusion
Last update: | n= | updated weekly
Fig 2) PsoBest registry: patient numbers by non-biologic treatment at inclusion

 

Show table for Fig. 1/2Hide table

Inclusion Treatment Patient Number of that with similar agents (e.g. Biosimilars)
Adalimumab 951 30
Brodalumab 162 0
Certolizumab 36 0
Efalizumab 35 0
Etanercept 304 45
Golimumab 26 0
Guselkumab 271 0
Infliximab 100 1
Ixekizumab 247 0
Secukinumab 989 0
Tildrakizumab 44 0
Ustekinumab 651 0
Apremilast 383 0
Ciclosporin 361 0
Fumaderm 2528 0
Skilarence 880 0
Methotrexate 2514 0
other systemics 345 0

 

Fig. 3) Rate of patients by medication class at inclusion
Last update: | n= | updated weekly
Fig. 3) Rate of patients by medication class at inclusion

 

Fig. 4) Rate of patients by type of registry site
Last update: | n= | updated weekly
Fig. 4) Rate of patients by type of registry site

 

Fig. 5) Registered PsoBest centers
Last update: | n= | updated monthly
Fig. 5) Registered PsoBest centers